BCYC: A Promising Play In The Biotech Sector
October 01, 2024 at 00:20 AM EDT
The long-awaited and overdue half-point cut in the federal funds rate was the impetus for the SPDR Biotech ETF to finally break above the 102-103 level. Meanwhile, Bicycle Therapeutics Plc. had a strong ESMO following promising new data
